Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death von Muchtar, Eli, Gertz, Morie A., Kumar, Shaji K., Lacy, Martha Q., Dingli, David, Buadi, Francis K., Grogan, Martha, Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Fonder, Amie, Hobbs, Miriam, Hwa, Yi Lisa, Gonsalves, Wilson, Warsame, Rahma, Kourelis, Taxiarchis V., Russell, Stephen, Lust, John A., Lin, Yi, Go, Ronald S., Zeldenrust, Steven, Kyle, Robert A., Rajkumar, S.Vincent, Dispenzieri, Angela

Volltext

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria von Lakshman, Arjun, Rajkumar, S. Vincent, Buadi, Francis K., Binder, Moritz, Gertz, Morie A., Lacy, Martha Q., Dispenzieri, Angela, Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Hwa, Yi Lisa, Kapoor, Prashant, Leung, Nelson, Go, Ronald S., Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Lust, John A., Russell, Stephen J., Zeldenrust, Steven R., Kyle, Robert A., Kumar, Shaji K.

Volltext

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma von Goyal, Gaurav, Rajkumar, S. Vincent, Lacy, Martha Q., Gertz, Morie A., Buadi, Francis K., Dispenzieri, Angela, Hwa, Yi L., Fonder, Amie L., Hobbs, Miriam A., Hayman, Suzanne R., Zeldenrust, Steven R., Lust, John A., Russell, Stephen J., Leung, Nelson, Kapoor, Prashant, Go, Ronald S., Gonsalves, Wilson I., Kourelis, Taxiarchis V., Warsame, Rahma, Kyle, Robert A., Kumar, Shaji K.

Volltext

Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia von Sidana, Surbhi, Rajkumar, S. Vincent, Dispenzieri, Angela, Lacy, Martha Q., Gertz, Morie A., Buadi, Francis K., Hayman, Suzanne R., Dingli, David, Kapoor, Prashant, Gonsalves, Wilson I., Go, Ronald S., Hwa, Yi Lisa, Leung, Nelson, Fonder, Amie L., Hobbs, Miriam A., Zeldenrust, Steven R., Russell, Stephen J., Lust, John A., Kyle, Robert A., Kumar, Shaji K.

Volltext

Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update von Muchtar, Eli, Dispenzieri, Angela, Gertz, Morie A., Kumar, Shaji K., Buadi, Francis K., Leung, Nelson, Lacy, Martha Q., Dingli, David, Ailawadhi, Sikander, Bergsagel, P. Leif, Fonseca, Rafael, Hayman, Suzanne R., Kapoor, Prashant, Grogan, Martha, Abou Ezzeddine, Omar F., Rosenthal, Julie L., Mauermann, Michelle, Siddiqui, Mustaqueem, Gonsalves, Wilson I., Kourelis, Taxiarchis V., Larsen, Jeremy T., Reeder, Craig B., Warsame, Rahma, Go, Ronald S., Murray, David L., McPhail, Ellen D., Dasari, Surendra, Jevremovic, Dragan, Kyle, Robert A., Lin, Yi, Lust, John A., Russell, Stephen J., Hwa, Yi Lisa, Fonder, Amie L., Hobbs, Miriam A., Rajkumar, S. Vincent, Roy, Vivek, Sher, Taimur

Volltext

Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival von Charalampous, Charalampos, Goel, Utkarsh, Kapoor, Prashant, Binder, Moritz, Buadi, Francis K., Dingli, David, Dispenzieri, Angela, Fonder, Amie L., Gertz, Morie A., Gonsalves, Wilson, Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi L., Kourelis, Taxiarchis, Lacy, Martha Q., Leung, Nelson, Lin, Yi, Warsame, Rahma, Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji

Volltext

Efficacy of VDT PACE‐like regimens in treatment of relapsed/refractory multiple myeloma von Lakshman, Arjun, Singh, Preet Paul, Rajkumar, S. Vincent, Dispenzieri, Angela, Lacy, Martha Q., Gertz, Morie A., Buadi, Francis K., Dingli, David, Hwa, Yi Lisa, Fonder, Amie L., Hobbs, Miriam, Hayman, Suzanne R., Zeldenrust, Steven R., Lust, John A., Russell, Stephen J., Leung, Nelson, Kapoor, Prashant, Go, Ronald S., Lin, Yi, Gonsalves, Wilson I., Kourelis, Taxiarchis, Warsame, Rahma, Kyle, Robert A., Kumar, Shaji K.

Volltext

Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma von Goel, Utkarsh, Charalampous, Charalampos, Kapoor, Prashant, Binder, Moritz, Buadi, Francis K., Dingli, David, Dispenzieri, Angela, Fonder, Amie, Gertz, Morie A., Gonsalves, Wilson I., Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi L., Kourelis, Taxiarchis, Lacy, Martha Q., Leung, Nelson, Lin, Yi, Warsame, Rahma M., Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K.

Volltext

Monoclonal Gammopathy of Undetermined Significance: Indications for Prediagnostic Testing, Subsequent Diagnoses, and Follow-up Practice at Mayo Clinic von Ravindran, Aishwarya, Lackore, Kandace A., Glasgow, Amy E., Drake, Matthew T., Hobbs, Miriam A., Kourelis, Taxiarchis, Kumar, Shaji, Kyle, Robert A., Leung, Nelson, Muchtar, Eli, Go, Ronald S.

Volltext

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse von Sidana, Surbhi, Tandon, Nidhi, Dispenzieri, Angela, Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Warsame, Rahma M., Kourelis, Taxiarchis, Hwa, Yi Lisa, Kapoor, Prashant, Kyle, Robert A., Leung, Nelson, Go, Ronald S., Rajkumar, S. Vincent, Kumar, Shaji K.

Volltext

Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide von Goel, Utkarsh, Charalampous, Charalampos, Kapoor, Prashant, Binder, Moritz, Buadi, Francis K., Dingli, David, Dispenzieri, Angela, Fonder, Amie, Gertz, Morie A., Gonsalves, Wilson I., Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi L., Kourelis, Taxiarchis, Lacy, Martha Q., Leung, Nelson, Lin, Yi, Warsame, Rahma M., Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K.

Volltext

Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma von Charalampous, Charalampos, Goel, Utkarsh, Kapoor, Prashant, Binder, Moritz, Buadi, Francis K., Cook, Joselle, Dingli, David, Dispenzieri, Angela, Fonder, Amie L., Gertz, Morie A., Gonsalves, Wilson, Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi L., Kourelis, Taxiarchis, Lacy, Martha Q., Leung, Nelson, Lin, Yi, Warsame, Rahma, Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K.

Volltext

Venetoclax for the treatment of translocation (11;14) AL amyloidosis von Sidiqi, M. Hasib, Al Saleh, Abdullah S., Leung, Nelson, Jevremovic, Dragan, Aljama, Mohammed A., Gonsalves, Wilson I., Buadi, Francis K., Kourelis, Taxiarchis V., Warsame, Rahma, Muchtar, Eli, Hobbs, Miriam A., Lacy, Martha Q., Dingli, David, Go, Ronald S., Hayman, Suzanne R., Rajkumar, S. Vincent, Dispenzieri, Angela, Gertz, Morie A., Kumar, Shaji K., Fonseca, Rafael, Kapoor, Prashant

Volltext

Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation von Abdallah, Nadine H., Habermann, Thomas, Buadi, Francis K., Gertz, Morie A., Lacy, Martha Q., Rajkumar, S. Vincent, Dingli, David, Go, Ronald S., Hayman, Suzanne R., Kumar, Shaji K., Kourelis, Taxiarchis, Warsame, Rahma, Kapoor, Prashant, Muchtar, Eli, Hwa, Yi L., Fonder, Amie L., Hobbs, Miriam A., Lin, Yi, Leung, Nelson, Binder, Moritz, Siddiqui, Mustaqeem A., Kyle, Robert A., Witzig, Thomas E., Dispenzieri, Angela

Volltext

Delineation of the timing of second-line therapy post–autologous stem cell transplant in patients with AL amyloidosis von Hwa, Yi L., Warsame, Rahma, Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Kumar, Shaji K., Dingli, David, Zeldenrust, Steve R., Leung, Nelson, Hayman, Susanne R., Kapoor, Prashant, Gonsalves, Wilson I., Kourelis, Taxiarchis V., Russell, Stephen, Go, Ronald S., Hobbs, Miriam A., Fonder, Amie L., Rajkumar, S.Vincent, Dispenzieri, Angela

Volltext

Prognostic significance of acquired 1q22 gain in multiple myeloma von Audil, Hadiyah Y., Cook, Joselle M., Greipp, Patricia T., Kapoor, Prashant, Baughn, Linda B., Dispenzieri, Angela, Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Muchtar, Eli, Siddiqui, Mustaqeem, Gonsalves, Wilson I., Hwa, Yi Lisa, Leung, Nelson, Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Kyle, Robert A., Ketterling, Rhett P., Rajkumar, S. Vincent, Kumar, Shaji K.

Volltext

Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies von McCullough, Kristen B., Hobbs, Miriam A., Abeykoon, Jithma P., Kapoor, Prashant

Volltext

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy von Tschautscher, Marcella A., Jevremovic, Dragan, Rajkumar, Vincent, Dispenzieri, Angela, Lacy, Martha Q., Gertz, Morie A., Buadi, Francis K., Dingli, David, Hwa, Yi L., Fonder, Amie L., Hobbs, Miriam A., Hayman, Suzanne R., Zeldenrust, Steven R., Lust, John A., Russell, Stephen J., Leung, Nelson, Kapoor, Prashant, Go, Ronald S., Lin, Yi, Gonsalves, Wilson I., Kourelis, Taxiarchis, Warsame, Rahma, Kyle, Robert A., Kumar, Shaji K.

Volltext

Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort von Drosou, Maria Eleni, Vaughan, Lisa E., Muchtar, Eli, Buadi, Francis K., Dingli, David, Dispenzieri, Angela, Fonder, Amie L., Gertz, Morie A., Go, Ronald S., Gonsalves, Wilson I., Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi L., Kapoor, Prashant, Kourelis, Taxiarchis, Kumar, Shaji, Kyle, Robert A., Lacy, Martha Q., Lin, Yi, Lopez, Camden L., Lust, John A., Rajkumar, S. Vincent, Russell, Stephen J., Sidana, Surbhi, Siddiqui, Mustaqeem A., Sidiqi, M. Hasib, Warsame, Rahma, Leung, Nelson

Volltext

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis von Hwa, Yi L., Gertz, Morie A., Kumar, Shaji K., Lacy, Martha Q., Buadi, Francis K., Dingli, David, Kapoor, Prashant, Zeldenrust, Steve R., Leung, Nelson, Hayman, Susanne R., Gonsalves, Wilson I., Kourelis, Taxiarchis V., Warsame, Rahma, Go, Ronald S., Muchtar, Eli, Hobbs, Miriam A., Fonder, Amie L., Russell, Stephen, Kyle, Robert A., Rajkumar, S. Vincent, Dispenzieri, Angela

Volltext